+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immobilized Penicillin G Acylase Market - Global Forecast 2025-2030- Product Image
Immobilized Penicillin G Acylase Market - Global Forecast 2025-2030- Product Image
Sale

Immobilized Penicillin G Acylase Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127930
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immobilized Penicillin G Acylase is redefining antibiotic manufacturing processes, delivering enhanced catalytic stability and process efficiency for the global pharmaceutical industry. Senior leaders navigating regulatory pressures and supply chain complexity are leveraging these advancements to secure operational resilience and sustainable growth.

Market Snapshot: Immobilized Penicillin G Acylase Market

The market for immobilized Penicillin G Acylase is characterized by robust expansion, driven by its integral role in modern antibiotic synthesis. Key contributing factors include rising global pharmaceutical demand, ongoing supply chain optimization, and the need for sustainable production methods. Escalating regulatory requirements are influencing investment in advanced biocatalysis and continuous processing platforms. The market exhibits notable geographic diversity, with North America, Europe, and Asia-Pacific leading innovation and adoption trends. Heightened industry collaboration and real-time digital analytics are further transforming operational approaches.

Scope & Segmentation

  • Applications:
    • Beta-lactam antibiotics production (including amoxicillin, ampicillin, and novel beta-lactam synthesis)
    • Cephalosporin production focused on 7-amino cephalosporanic acid
  • Carrier Types:
    • Inorganic silica and magnetic nanoparticles
    • Organic polymers: natural (alginate, chitosan) and synthetic (polyacrylamide, polystyrene)
    • Resin supports
  • Immobilization Methods:
    • Adsorption
    • Covalent binding (chemical cross-linking, spacer arm techniques)
    • Cross-linking, encapsulation, entrapment
  • End Use Industries:
    • Contract manufacturing organizations
    • Diagnostics
    • Food processing
    • Pharmaceutical manufacturing (generic and innovator)
  • Process Types:
    • Batch process
    • Continuous process (fluidized bed reactor, packed bed reactor)
  • Enzyme Sources:
    • Recombinant strains (e.g., Bacillus subtilis, Escherichia coli)
    • Wild strains
  • Product Forms:
    • Beads (gel and porous types)
    • Granules
    • Powder
  • Regional Coverage:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Companies:
    • Novozymes A/S
    • Royal DSM N.V.
    • Codexis, Inc.
    • Amano Enzyme Inc.
    • EnzymeWorks (Suzhou) Co., Ltd.
    • Biocatalysts Ltd.
    • Sanzyme Biologics Limited
    • Creative Enzymes Co., Ltd.
    • Zhejiang Konson Biotech Co., Ltd.
    • Nakai Chemicals Co., Ltd.

Key Takeaways for Decision-Makers

  • Immobilized Penicillin G Acylase extends operational lifespans, enabling lower reagent consumption and streamlined post-processing.
  • Advanced carrier technologies and immobilization techniques offer increased productivity and catalytic stability, essential for robust antibiotic supply chains.
  • Continuous processing platforms, such as fluidized and packed bed reactors, are replacing batch operations, driving process intensification and higher throughput.
  • Strategic collaborations across biochemistry, materials science, and engineering foster rapid innovation, accelerating adoption and integration of novel solutions.
  • Regional shifts—such as localized enzyme manufacturing and partnerships—strengthen supply chain resilience and cut logistical lead times, especially in response to evolving regulatory conditions.
  • Circular economy practices, including enzyme recycling and carrier reactivation, align with sustainability initiatives and regulatory expectations within the pharmaceutical sector.

Tariff Impact: Strategic Realignment in Response to U.S. Regulatory Changes

Revised United States tariffs implemented in 2025 have prompted companies to revisit sourcing and procurement strategies for immobilized Penicillin G Acylase. Increased import duties on carriers and reagents are accelerating the trend towards regional manufacturing and geographically co-located partnerships. As a result, industry players are prioritizing process intensification and focused R&D in enzyme recycling to mitigate cost pressures while maintaining uninterrupted antibiotic supply.

Methodology & Data Sources

This analysis integrates secondary research—including industry literature, patent databases, regulatory filings, and corporate disclosures—alongside expert interviews with bioprocess engineers and materials scientists. Direct case studies validate performance benchmarks across regions. Cross-validation ensures insight reliability, and regulatory as well as sustainability considerations are consistently addressed.

Why This Report Matters

  • Provides senior decision-makers with comprehensive insights into evolving supply chain strategies, regulatory impacts, and innovation within immobilized Penicillin G Acylase applications.
  • Equips leaders to identify region-specific opportunities, best-in-class process technologies, and partnership models to enhance manufacturing resilience and resource efficiency.

Conclusion

This report delivers a concise evaluation of market dynamics, technological advancements, and strategic opportunities in immobilized Penicillin G Acylase. Leaders equipped with these insights are positioned to drive operational excellence and sustainable pharmaceutical manufacturing outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of green immobilization techniques to reduce environmental footprint in penicillin G acylase production
5.2. Integration of advanced nanomaterial-based supports to boost enzyme activity and stability in PGA immobilization
5.3. Implementation of continuous flow reactors with immobilized penicillin G acylase for high-throughput antibiotic synthesis
5.4. Development of genetically engineered recombinant penicillin G acylase strains for enhanced immobilization yields
5.5. Regulatory and quality control challenges in scaling up immobilized penicillin G acylase processes for pharmaceutical use
5.6. Cost optimization strategies through carrier recycling and enzyme reuse in immobilized penicillin G acylase operations
5.7. Impact of emerging solvent engineering methods on the operational stability of immobilized penicillin G acylase
5.8. Collaboration between biotech startups and contract manufacturers to innovate immobilized enzyme platforms for ß-lactam production
5.9. Advances in computational modeling for predicting performance of immobilization matrices for penicillin G acylase
5.10. Market implications of shifting antibiotic production to immobilized penicillin G acylase-based continuous manufacturing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immobilized Penicillin G Acylase Market, by Application
8.1. Introduction
8.2. Beta-Lactam Antibiotics Production
8.2.1. Amoxicillin Production
8.2.2. Ampicillin Production
8.2.3. Novel Beta-Lactam Synthesis
8.3. Cephalosporin Production
8.3.1. 7-Amino Cephalosporanic Acid Production
9. Immobilized Penicillin G Acylase Market, by Carrier Type
9.1. Introduction
9.2. Inorganic Silica
9.3. Magnetic Nanoparticles
9.4. Organic Polymer
9.4.1. Natural Polymer
9.4.1.1. Alginate
9.4.1.2. Chitosan
9.4.2. Synthetic Polymer
9.4.2.1. Polyacrylamide
9.4.2.2. Polystyrene
9.5. Resin
10. Immobilized Penicillin G Acylase Market, by Immobilization Method
10.1. Introduction
10.2. Adsorption
10.3. Covalent Binding
10.3.1. Chemical Cross-Linking
10.3.2. Spacer Arm Techniques
10.4. Cross-Linking
10.5. Encapsulation
10.6. Entrapment
11. Immobilized Penicillin G Acylase Market, by End Use Industry
11.1. Introduction
11.2. Contract Manufacturing Organizations
11.3. Diagnostics
11.4. Food Processing
11.5. Pharmaceutical Manufacturing
11.5.1. Generic Manufacturing
11.5.2. Innovator Manufacturing
12. Immobilized Penicillin G Acylase Market, by Process Type
12.1. Introduction
12.2. Batch Process
12.3. Continuous Process
12.3.1. Fluidized Bed Reactor
12.3.2. Packed Bed Reactor
13. Immobilized Penicillin G Acylase Market, by Enzyme Source
13.1. Introduction
13.2. Recombinant Strains
13.2.1. Bacillus Subtilis
13.2.2. Escherichia Coli
13.3. Wild Strains
14. Immobilized Penicillin G Acylase Market, by Product Form
14.1. Introduction
14.2. Beads
14.2.1. Gel Beads
14.2.2. Porous Beads
14.3. Granules
14.4. Powder
15. Americas Immobilized Penicillin G Acylase Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Immobilized Penicillin G Acylase Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Immobilized Penicillin G Acylase Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Novozymes a/S
18.3.2. Royal DSM N.V.
18.3.3. Codexis, Inc.
18.3.4. Amano Enzyme Inc.
18.3.5. EnzymeWorks (Suzhou) Co., Ltd.
18.3.6. Biocatalysts Ltd.
18.3.7. Sanzyme Biologics Limited
18.3.8. Creative Enzymes Co., Ltd.
18.3.9. Zhejiang Konson Biotech Co., Ltd.
18.3.10. Nakai Chemicals Co., Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. IMMOBILIZED PENICILLIN G ACYLASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. IMMOBILIZED PENICILLIN G ACYLASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. IMMOBILIZED PENICILLIN G ACYLASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. IMMOBILIZED PENICILLIN G ACYLASE MARKET: RESEARCHAI
FIGURE 30. IMMOBILIZED PENICILLIN G ACYLASE MARKET: RESEARCHSTATISTICS
FIGURE 31. IMMOBILIZED PENICILLIN G ACYLASE MARKET: RESEARCHCONTACTS
FIGURE 32. IMMOBILIZED PENICILLIN G ACYLASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMOBILIZED PENICILLIN G ACYLASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY AMOXICILLIN PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY AMOXICILLIN PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY AMPICILLIN PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY AMPICILLIN PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NOVEL BETA-LACTAM SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NOVEL BETA-LACTAM SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY 7-AMINO CEPHALOSPORANIC ACID PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY 7-AMINO CEPHALOSPORANIC ACID PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY INORGANIC SILICA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY INORGANIC SILICA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY MAGNETIC NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY MAGNETIC NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ALGINATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ALGINATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CHITOSAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POLYACRYLAMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POLYACRYLAMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POLYSTYRENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POLYSTYRENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RESIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RESIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ADSORPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ADSORPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CHEMICAL CROSS-LINKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CHEMICAL CROSS-LINKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SPACER ARM TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SPACER ARM TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CROSS-LINKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CROSS-LINKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENCAPSULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENCAPSULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENTRAPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENTRAPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GENERIC MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GENERIC MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY INNOVATOR MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY INNOVATOR MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BATCH PROCESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BATCH PROCESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY FLUIDIZED BED REACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY FLUIDIZED BED REACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PACKED BED REACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PACKED BED REACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BACILLUS SUBTILIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BACILLUS SUBTILIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY WILD STRAINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY WILD STRAINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GEL BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GEL BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POROUS BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POROUS BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 202. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 203. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 204. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 205. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 208. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 209. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 210. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 211. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 212. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 213. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 214. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 215. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 216. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 217. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 218. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 219. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 220. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 221. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2018-2024 (USD MILLION)
TABLE 224. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2025-2030 (USD MILLION)
TABLE 225. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2018-2024 (USD MILLION)
TABLE 226. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2025-2030 (USD MILLION)
TABLE 227. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2018-2024 (USD MILLION)
TABLE 228. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2025-2030 (USD MILLION)
TABLE 229. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 230. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 231. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2018-2024 (USD MILLION)
TABLE 232. CANADA IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 236. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 237. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 242. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 243. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 244. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 245. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 246. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 247. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 248. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 249. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 250. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 251. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 252. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 253. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 254. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 255. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CONTINUOUS PROCESS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ENZYME SOURCE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY RECOMBINANT STRAINS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 264. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 265. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2018-2024 (USD MILLION)
TABLE 266. MEXICO IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BEADS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY BETA-LACTAM ANTIBIOTICS PRODUCTION, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CEPHALOSPORIN PRODUCTION, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY CARRIER TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY ORGANIC POLYMER, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY NATURAL POLYMER, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY SYNTHETIC POLYMER, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY IMMOBILIZATION METHOD, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY COVALENT BINDING, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY END USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL IMMOBILIZED PENICILLIN G ACYLASE MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL IMMOBILIZED

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immobilized Penicillin G Acylase market report include:
  • Novozymes A/S
  • Royal DSM N.V.
  • Codexis, Inc.
  • Amano Enzyme Inc.
  • EnzymeWorks (Suzhou) Co., Ltd.
  • Biocatalysts Ltd.
  • Sanzyme Biologics Limited
  • Creative Enzymes Co., Ltd.
  • Zhejiang Konson Biotech Co., Ltd.
  • Nakai Chemicals Co., Ltd.

Related Topics

Related Reports

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2025-2030 - Product Image

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Penicillin G Acylase - Global Strategic Business Report - Product Image

Penicillin G Acylase - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
ß-lactam antibiotics Intermediates 6-APA Market - Global Forecast 2025-2030 - Product Image

ß-lactam antibiotics Intermediates 6-APA Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Penicillin G N-Ethylpiperidine Salt (CAS 39879-63-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Penicillin G N-Ethylpiperidine Salt (CAS 39879-63-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.